Unlocking Tumor Vascular Barriers With CXCR3: Implications for Cancer Immunotherapy

OncoImmunology - United States
doi 10.1080/2162402x.2015.1116675
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Tumor-Induced Myeloid Dysfunction and Its Implications for Cancer Immunotherapy

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2014English

Human Tumor Antigens and Cancer Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology

Rheumatic Disease Clinics of North America
Rheumatology
2017English

Combined Yeast-Derived Β-Glucan With Anti-Tumor Monoclonal Antibody for Cancer Immunotherapy

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Optimizing Tumor Microenvironment for Cancer Immunotherapy: Β-Glucan-Based Nanoparticles

Frontiers in Immunology
AllergyImmunology
2018English

Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer Immunotherapy

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

Clinical and Developmental Immunology
2012English

Reprogramming the Microenvironment With Tumor-Selective Angiotensin Blockers Enhances Cancer Immunotherapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Tumor Immunity and Autoimmunity Following Cancer Immunotherapy

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy